Bone News and Research

RSS

Balanced diet and exercise are the only reliable ways to lose weight

It's time to set the record straight. The only reliable way to lose weight is to eat less or exercise more. Preferably both.

7 Jan 2010

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

Gilead Sciences, Inc. today announced that a Phase II clinical trial of its investigational integrase inhibitor-based, once-daily, fixed-dose “Quad” regimen of elvitegravir, GS 9350 and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV-1 infection met its primary objective.

7 Jan 2010

MSU researcher discovers link between diabetes and bone marrow nerve damage

A research team led by a Michigan State University professor has discovered a link between diabetes and bone marrow nerve damage that may help treat one of the disease's most common and potentially blindness-causing complications.

7 Jan 2010

MabCure signs clinical research agreement to diagnose ovarian cancer

MabCure, N.V. (“MabCure”) a wholly-owned subsidiary of MabCure Inc., a biotech company that has developed a series of highly specific monoclonal antibodies (MAbs) to combat various types of cancers, has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand.

7 Jan 2010

BioMimetic Therapeutics amends and restates its agreement with Novartis Vaccines and Diagnostics

BioMimetic Therapeutics, Inc. today announced that effective December 31, 2009, the Company amended and restated its manufacturing and supply agreement with Novartis Vaccines and Diagnostics, Inc. for the supply of bulk rhPDGF-BB to BioMimetic.

6 Jan 2010

Weill Cornell Medical College offers innovative program to teach medical students about health care system

While medical students are required to know the names of every body part and disease, most graduate with only a cursory understanding of how the health care system actually works, and some of the ways it doesn't.

6 Jan 2010

American Red Cross offers tips to stay warm in bone chilling temperatures

Bone chilling temperatures have gripped much of the country, and the American Red Cross urges everyone to be safe and prepare as much as possible.

6 Jan 2010

Scott & White's CRI launches two clinical trials targeting cancers

Scott & White's Cancer Research Institute (CRI) has launched two clinical trials targeting cancers that affect both adults and children.

6 Jan 2010

Biomet reports second quarter financial results for fiscal 2010

Biomet, Inc. net sales increased 8% during the second fiscal quarter ended November 30, 2009, to $695.6 million from $642.8 million during the second quarter of fiscal year 2009. On a constant currency basis, net sales increased 5% during the second quarter of fiscal 2010.

6 Jan 2010

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), fat mass is important in increasing bone size and thickness, but this effect appears to be stronger in girls than boys.

6 Jan 2010

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

Vitamin D deficiency may contribute to a higher number of heart and stroke-related deaths among black Americans compared to whites, according to a University of Rochester Medical Center study.

6 Jan 2010

$HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture$

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), postmenopausal HIV-infected women have a high prevalence of low bone mineral density and high bone turnover placing them at high risk for future bone fractures.

5 Jan 2010

Fish oil supplement now available in water-soluble drink

Nordic Naturals, the industry leader in omega-3 fish oil, introduces Omega-3 Effervescent, an innovative way to enjoy fish oil supplementation via a water-soluble drink mix containing EPA and DHA in a delicious orange flavor.

5 Jan 2010

Despite economic downturn, Russia still represents a promising healthcare market

Despite uncertain economic environment, Russia still represents a promising healthcare market with strong potential for further growth.

5 Jan 2010

NQF endorses 70 measures to improve gathering of clinical electronic data

As an incremental step toward wider use of electronic data platforms to measure, report, and improve quality, the National Quality Forum (NQF) has endorsed 70 measures that combine data from two or more common electronic sources such as administrative claims, pharmacy and laboratory systems, and registries.

5 Jan 2010

RFA reduces pain in bone metastases patients

Image-guided radiofrequency ablation (RFA), a minimally invasive cancer treatment which can be performed in the outpatient setting, significantly reduced the level of pain experienced by cancer patients with bone (osseous) metastases, limiting the need for strong narcotic pain management, and supporting improved patient frame of mind, according to results of an American College of Radiology Imaging Network (ACRIN) study published online in the journal Cancer.

5 Jan 2010

Study shows low postoperative mortality rates after hip and knee replacement surgeries

Total hip and total knee replacement surgeries are highly successful and very common procedures for people experiencing pain associated with degenerative joints.

5 Jan 2010

Changes needed in orthopedic training programs, but restrictions and generational differences compromise learning experience

Changes are needed in the programs that train orthopedic surgeons to ensure these doctors are adequately trained, according to a study by researchers at Hospital for Special Surgery (HSS) in New York City.

5 Jan 2010

VELCADE sNDA receives FDA approval

Millennium: The Takeda Oncology Company today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE, which expands the label to include long-term (median follow-up 36.7 months) overall survival (OS) data from the landmark VISTA trial and provides specific dosing recommendations for patients with hepatic impairment. The VISTA trial examined the use of VELCADE based therapy in patients with previously untreated multiple myeloma (MM).

5 Jan 2010

Headline results from first phase III study of Balaglitazone announced

Dr. Reddy’s Laboratories Ltd. and Rheoscience, a subsidiary of Nordic Bioscience A/S, today announced the headline results from the first phase III study for their investigational agent, Balaglitazone.

4 Jan 2010

Bone News and Research

Balanced diet and exercise are the only reliable ways to lose weight

Phase II clinical trial of Gilead Sciences' elvitegravir, GS 9350 and Truvada meets primary objective

MSU researcher discovers link between diabetes and bone marrow nerve damage

MabCure signs clinical research agreement to diagnose ovarian cancer

BioMimetic Therapeutics amends and restates its agreement with Novartis Vaccines and Diagnostics

Weill Cornell Medical College offers innovative program to teach medical students about health care system

American Red Cross offers tips to stay warm in bone chilling temperatures

Scott & White's CRI launches two clinical trials targeting cancers

Biomet reports second quarter financial results for fiscal 2010

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

Vitamin D deficiency may contribute to higher risk of death among African-Americans compared to whites

HIV-infected postmenopausal women face higher risk for accelerated bone loss and fracture

Fish oil supplement now available in water-soluble drink

Despite economic downturn, Russia still represents a promising healthcare market

NQF endorses 70 measures to improve gathering of clinical electronic data

RFA reduces pain in bone metastases patients

Study shows low postoperative mortality rates after hip and knee replacement surgeries

Changes needed in orthopedic training programs, but restrictions and generational differences compromise learning experience

VELCADE sNDA receives FDA approval

Headline results from first phase III study of Balaglitazone announced

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News